- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix | ||
| 11.02. | AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections | ||
| 11.02. | Eli Lilly shares two-year results for Omvoh in active Crohn's disease patients | ||
| 11.02. | Inizio appoints Jim Sage as president of Inizio Engage | ||
| 10.02. | Inizio appoints Remco op den Kelder as president of Inizio Advisory | ||
| 10.02. | Roche announces positive late-stage results for Gazyva/Gazyvaro in lupus nephritis | ||
| 10.02. | CHMP recommends Bavarian Nordic's chikungunya vaccine for individuals aged from 12 years | ||
| 07.02. | Novo Nordisk's haemophilia A therapy Mim8 shows promise in late-stage study | ||
| 07.02. | International Alzheimer's disease prevention trial in at-risk young adults begins | ||
| 07.02. | Inizio appoints Colin Stanley as chief commercial officer | ||
| 06.02. | MHRA approves Valneva's chikungunya vaccine Ixchiq for use in adults | ||
| 06.02. | BMS receives CHMP recommendation for Breyanzi in follicular lymphoma | ||
| 06.02. | LEO and DEBRA Research partner to advance epidermolysis bullosa treatments | ||
| 06.02. | Shaping the future of pharma with human-centric transformation techniques | ||
| 05.02. | Novartis' Kisqali granted MHRA approval to treat early breast cancer patients | ||
| 05.02. | FDA approves Supernus Pharmaceuticals' Onapgo to treat advanced Parkinson's disease | ||
| 05.02. | Merck's adult-specific pneumococcal vaccine Capvaxive recommended by CHMP | ||
| 05.02. | GenAI and healthcare - potential that goes beyond established technologies | ||
| 04.02. | UK government launches 'landmark' AI breast cancer screening trial | ||
| 04.02. | World Cancer Day - CoppaFeel! and NHS NELCA urge young people to 'Check In' | ||
| 04.02. | Pfizer announces positive phase 3 results for Braftovi regimen in colorectal cancer | ||
| 04.02. | BMS receives CHMP recommendation for Opdivo/Yervoy combination in liver cancer | ||
| 04.02. | Celebrating collective achievement - the power of collaboration | ||
| 03.02. | AstraZeneca's Imfinzi recommended by CHMP to treat small cell lung cancer | ||
| 03.02. | J&J's subcutaneous Rybrevant receives positive CHMP opinion for advanced lung cancer |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
